Pharmaceutical industry’s response to the Ebola Bundibugyo virus disease outbreak
• A new outbreak of the Ebola Bundibugyo virus has emerged, affecting the Democratic Republic of Congo, Uganda, and surrounding neighboring countries. • Pharmaceutical and biotech companies are collaborating with global health and humanitarian partners to coordinate a rapid medical response. • This industry involvement is critical to accelerating the containment of the virus and providing necessary treatments to affected populations.
ifpma.org
